Black women with breast cancer have worse outcomes despite receiving equivalent treat

[News]

Even with equivalent treatments in women with hormone receptor-positive, HER2-negative breast cancer, black women had significantly higher breast cancer recurrence and increased overall mortality compared to white women in a large phase III clinical trial, TAILORx, according to data presented at the 2018 San Antonio Breast Cancer Symposium, held Dec. 4-8.

More... (https://www.news-medical.net/news/20181207/Black-women-with-breast-cancer-have-worse-outcomes-despite-receiving-equivalent-treatments-as-white-women.aspx)